BM Calc Phos (calcarea phosphorica) NDC 82969-1102

NDC codes

FDA NDC Directory

Product NDC (as listed)82969-1102Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82969-1102Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82969-1102-1	82969110201	30000 mg in 1 BOTTLE, GLASS (82969-1102-1)Marketed from Jan 1, 2015
82969-1102-2	82969110202	500000 mg in 1 JAR (82969-1102-2)Marketed from Jan 1, 2015

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): BM Calc Phos
Generic name (nonproprietary): calcarea phosphorica
Active ingredients: Tribasic calcium phosphate — 6 [hp_X]/60mg
Dosage form: Tablet
Route: Oral
Labeler: Total Operations Management LLC DBA:Bestmade Natural Products Micro
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jan 1, 2015
Listing expires: Dec 31, 2027
Identifiers: Product ID 82969-1102_53ba833d-a860-f3f2-e063-6394a90a8639SPL ID 53ba833d-a860-f3f2-e063-6394a90a8639SPL set ID 53ba8260-0f5a-ff74-e063-6294a90ad30aUNII 91D9GV0Z28

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482969110201 followed by a unit qualifier and the quantity

Package 82969-1102-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 8, 2026.

Indications (excerpt from the label)

Helps temporarily relieve: feelings of exhaustion during recovery from illness; discomfort associated with growth-related issues, such as delayed tooth development and recovery from broken bones; and discomfort associated with low iron and thinness.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)